Age-Related Changes and Effects of Bisphosphonates on Bone Turnover and Disease Progression in Fibrous Dysplasia of Bone.

Florenzano, Pablo; Pan, Kristen S; Brown, Sydney M; Paul, Scott M; Kushner, Harvey; Guthrie, Lori C; de Castro, Luis Fernandez; Collins, Michael T; Boyce, Alison M

Florenzano, Pablo; Pan, Kristen S; Brown, Sydney M; Paul, Scott M; Kushner, Harvey; Guthrie, Lori C; de Castro, Luis Fernandez; Collins, Michael T; Boyce, Alison M.

Afiliação

Florenzano P; Skeletal Diseases and Mineral Homeostasis Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.
Pan KS; Department of Endocrinology, School of Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile.
Brown SM; Skeletal Diseases and Mineral Homeostasis Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.
Paul SM; Skeletal Diseases and Mineral Homeostasis Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.
Kushner H; Rehabilitation Medicine Department, Mark O. Hatfield Clinical Research Center, National Institutes of Health, Bethesda, MD, USA.
Guthrie LC; Biomedical Computer Research Institute, Philadelphia, PA, USA.
de Castro LF; Skeletal Diseases and Mineral Homeostasis Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.
Collins MT; Skeletal Diseases and Mineral Homeostasis Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.
Boyce AM; Skeletal Diseases and Mineral Homeostasis Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.

J Bone Miner Res ; 34(4): 653-660, 2019 04.

Article em En | MEDLINE | ID: mdl-30645769

Assuntos

Envelhecimento/metabolismo; Remodelação Óssea/efeitos dos fármacos; Difosfonatos/administração & dosagem; Displasia Fibrosa Óssea/tratamento farmacológico; Displasia Fibrosa Óssea/metabolismo; Adolescente; Adulto; Fatores Etários; Idoso; Idoso de 80 Anos ou mais; Envelhecimento/patologia; Biomarcadores/metabolismo; Criança; Pré-Escolar; Feminino; Fator de Crescimento de Fibroblastos 23; Displasia Fibrosa Óssea/epidemiologia; Displasia Fibrosa Óssea/patologia; Humanos; Masculino; Pessoa de Meia-Idade; Dor/epidemiologia; Dor/metabolismo; Dor/patologia; Prevalência

Palavras-chave

ANTIRESORPTIVES; BIOCHEMICAL MARKERS OF BONE TURNOVER; FIBROUS DYSPLASIA; MCCUNE-ALBRIGHT SYNDROME

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Envelhecimento / Remodelação Óssea / Difosfonatos / Displasia Fibrosa Óssea Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google